Diseases of the Prostate Flashcards
Lower urinary tract epidemiology
Effects 15-60% of men >40y
Patient impact: increased risk of falls, decreased QOL, depression, impaired ADL’s
Barriers to TX of Male GU Conditions
Poor provider/patient communication
Lack of knowledge (provider)
Embarrassment by the provider and patient
Etiology of Lower Urinary Tract symtpoms
Dysfunction of the bladder Dysfunction of the prostate Neurologic Disease Medical Conditions Medications
normal function of the bladder
Stores 300-500ml of urine
Empties to completion after a gentle urge
abnormal function of the bladder
(failure to store)
Voiding small amounts frequently
Uncontrollable urge (urgency) to empty
Incomplete emptying
What is the prostate gland?
Largest accessory gland of the male reproductive system
Firm, walnut shaped gland
Located at the base of the neck of the bladder
Urethra passes directly through the prostate
Contains small ducts that open into the prostatic portion of the urethra
Produces fluids that aid in reproduction
normal function of the prostate gland
Secretes prostatic fluid that is a thin, milky substance w/ an alkaline pH
Helps sperm survive in the acid environment of the female reproductive tract
Helps mobilize sperm after ejaculation
What is the overactive bladder syndrome
Syndrome including urinary urgency w/ or w/o incontinence, urinary frequency and nocturia
Benign Prostatic Hyperplasia (BPH)
Asymptomatic microscopic detection of prostatic hyperplasia, the benign proliferation of the prostate stroma and epithelium
Storage- Bladder Use
Urgency Frequency Nocturia Urge incontinence Stress incontinence Mixed incontinence Overflow incontinence
Voiding- Prostate use
Hesitancy Poor flow/weak stream Intermittency Straining to void Terminal dribbling Prolonged urination Urinary retention
Good flow, normal volume
consider other medical conditions
Voiding small amounts
think bladder
weak flow =
think prostate problem
Eval of LUTs
Detailed PE
Heart, lungs, abdomen, genitals, prostate and neuro
Laboratory Tests
U/A to r/o infection/hematuria, PSA
Prostate Conditions (acute and chronic causes of LUTS symptoms) (5)
BPH Acute Bacterial Prostatitis Nonbacterial Prostatitis Chronic Prostatitis Prostatodynia
3 main treatment approaches for OAB treatment
Pharmacologic therapy (eg, anticholinergic/antimuscarinic agents) Behavioral therapy (eg, bladder training, biofeedback, pelvic floor muscle therapy, and pelvic floor electrical stimulation) Surgical therapy
Pharmacological agents used for OAB treatment
Oxybutinin (Ditropan, Ditropan XL)
Fesoterodine (Toviaz)
Tolterodine (Detrol, Detrol LA)
Solifenacin
BPH
Most common benign tumor in men
? genetic component
Incidence increases with age, reaching 90% by the eighth decade of life
Pathophys for BPH
Characterized by proliferation of the prostate. Dihydrotestosterone (DHT) is the major hormone responsible for proliferation.
BPH produces nodules that compress the prostatic urethra
Signs/ Symptoms for BPH
Obstructive symptoms +/- irritative symptoms
Chronic obstruction predisposes to recurrent UTIs (d/t residual urine in the bladder)
Acute urinary obstruction may occur
Labs for BPH
U/A to exclude infection and hematuria: normal
?Serum Prostate Specific Antigen (PSA)
Normally used when screening for Prostate Cancer in combo w/ DRE
Imaging used for BPH
CT or renal ultrasound only if there is presence of other urinary tract disease or complications from BPH (hematuria, UTI, CKD, or hx of stone disease)
Cystoscopy only if considering surgery to help determine what approach to use
Treatment for BPH
Based on severity of disease
Options include watchful waiting, medical therapy, conventional surgical therapy and minimally invasive surgery
Watchful Waiting
Reserved for patients w/ mild disease
BPH medical therapy
α-Blockers
5α-reductase inhibitors
Phosphodiesterase-5 inhibitor
Combination Therapy= α-blocker + 5α-reductase inhibitors
α-Blockers MOA
: Relax the smooth muscle in the bladder neck and prostate gland
reducing bladder outlet obstruction and increasing peak urinary flow rates
side effects of α-Blockers
Orthostatic hypotension, dizziness, fatigue, retrograde ejaculation, rhinitis and HA
Usually given at night
α-1a Blockers
Receptors are localized to the prostate and bladder neck; therefore fewer systemic side effects
No dosage titration required
Ex. Tamsulosin (Flomax), Silodosin (Rapalfo)